To evaluate the relationships between the serum concentration of Erlotinib and the effects and toxicities of them

Trial Profile

To evaluate the relationships between the serum concentration of Erlotinib and the effects and toxicities of them

Recruiting
Phase of Trial: Phase II

Latest Information Update: 20 May 2014

At a glance

  • Drugs Erlotinib (Primary)
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Apr 2014 Planned number of patients changed from 26 to 20 as reported by University Hospital Medical Information Network - Japan.
    • 19 Jan 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top